Log in | Register

Bausch + Lomb Introduces the Putterman Consecutive CDCR Set

For the latest pharmaceutical news and updates - Sign up now!
Loading...
THURSDAY, FEBRUARY 24, 2011

ALISO VIEJO, Calif. -- Bausch + Lomb Instruments for Ophthalmology, Ear, Nose, Throat and Plastic Surgery announced the launch of the Putterman Consecutive Conjunctivodacryocystorhinostomy Set in the United States. Designed by Dr. Allen M. Putterman of Chicago, Illinois, this set is designed to form the CDCR osteum and place the bypass tube without withdrawal and reinsertion of instruments during each step of the procedure.

The set includes three instruments: a needle, trephine and probe. The needle is designed to create the initial track with the trephine used to slide over the needle to create the osteum. The needle is removed and the Bowman-type probe is inserted through the trephine. The trephine is then removed and the probe is used to measure the distance from medial canthus to nasal septum.

The probe features marks in 5.0 mm intervals from the tip to 15.0 mm, in 1.0 mm intervals from 15.0 mm to 25.0 mm, and again in 5.0 mm intervals from 25.0 mm to 35.0 mm.

For more information, to request a quote, or to place an order online, visit the Bausch + Lomb Instruments for Ear, Nose, Throat and Plastic Surgery web site at www.bauschinstruments.com. You may also contact Bausch + Lomb’s customer service support center at 1-800-338-2020 from 8:00 a.m. to 8:00 p.m. EST.

#  #  #

About Bausch + Lomb
Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, opthalmic surgical devices and instruments, and ophthamic pharmaceuticals. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.

SOURCE

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Measles Infections on the Rise in the U.S.

Measles Infections on the Rise in the U.S.

Apr 20 | Video

Just over a decade ago, U.S. health officials believed measles would be eradicated, but according to a new report from the Centers for Disease Control, infections are back and the numbers are growing. Dr. Nancy Snyderman, NBC's Chief Medical Editor reports.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter